Hypogonadism screening: Difference between revisions
| Line 3: | Line 3: | ||
{{CMG}} {{AE}} {{AEL}} | {{CMG}} {{AE}} {{AEL}} | ||
==Overview== | ==Overview== | ||
Hypogonadism screening is important in order to diagnose the disease early and provide the appropriate treatment. The endocrine society recommended screening for men patients who present with [[erectile dysfunction]], [[infertility]], [[HIV]] patients and young patients with [[Osteoporosis (patient information)|osteoporosis]]. | |||
==Screening== | ==Screening== | ||
Screening for hypogonadism is recommended by the endocrine society. It is recommended in men who are thought to be at high risk of having hypogonadism. Screening is performed in men showing the following:<ref name="pmid27132573">{{cite journal| author=Ross A, Bhasin S| title=Hypogonadism: Its Prevalence and Diagnosis. | journal=Urol Clin North Am | year= 2016 | volume= 43 | issue= 2 | pages= 163-76 | pmid=27132573 | doi=10.1016/j.ucl.2016.01.002 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=27132573 }} </ref> | Screening for hypogonadism is recommended by the endocrine society. It is recommended in men who are thought to be at high risk of having hypogonadism. Screening is performed in men showing the following:<ref name="pmid27132573">{{cite journal| author=Ross A, Bhasin S| title=Hypogonadism: Its Prevalence and Diagnosis. | journal=Urol Clin North Am | year= 2016 | volume= 43 | issue= 2 | pages= 163-76 | pmid=27132573 | doi=10.1016/j.ucl.2016.01.002 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=27132573 }} </ref> | ||
*Erectile dysfunction | *[[Erectile dysfunction]] | ||
*Infertility | *[[Infertility]] | ||
*HIV infected individuals | *[[HIV]] infected individuals | ||
*Men who got exposed to radiation on the brain | *Men who got exposed to [[radiation]] on the [[brain]] | ||
*Young patients with osteoporosis. | *Young patients with [[osteoporosis]]. | ||
==References== | ==References== | ||
{{Reflist|2}} | {{Reflist|2}} | ||
Revision as of 16:08, 14 July 2017
|
Hypogonadism Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Hypogonadism screening On the Web |
|
American Roentgen Ray Society Images of Hypogonadism screening |
|
Risk calculators and risk factors for Hypogonadism screening |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Ahmed Elsaiey, MBBCH [2]
Overview
Hypogonadism screening is important in order to diagnose the disease early and provide the appropriate treatment. The endocrine society recommended screening for men patients who present with erectile dysfunction, infertility, HIV patients and young patients with osteoporosis.
Screening
Screening for hypogonadism is recommended by the endocrine society. It is recommended in men who are thought to be at high risk of having hypogonadism. Screening is performed in men showing the following:[1]
- Erectile dysfunction
- Infertility
- HIV infected individuals
- Men who got exposed to radiation on the brain
- Young patients with osteoporosis.
References
- ↑ Ross A, Bhasin S (2016). "Hypogonadism: Its Prevalence and Diagnosis". Urol Clin North Am. 43 (2): 163–76. doi:10.1016/j.ucl.2016.01.002. PMID 27132573.